应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02269 药明生物
休市中 08-23 16:08:27
10.260
-0.140
-1.35%
最高
10.560
最低
10.160
成交量
4,856万
今开
10.240
昨收
10.400
日振幅
3.85%
总市值
426.13亿
流通市值
426.13亿
总股本
41.53亿
成交额
5.03亿
换手率
1.17%
流通股本
41.53亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
药明生物:未完成订单201亿美元
生物药大时代 · 08-23 15:56
药明生物:未完成订单201亿美元
又一家企业新增订单数超预期,医药CXO行业再次释放积极信号
中国制药网 · 08-23 15:42
又一家企业新增订单数超预期,医药CXO行业再次释放积极信号
药明生物(02269)下跌2.12%,报10.18元/股
金融界 · 08-23 14:45
药明生物(02269)下跌2.12%,报10.18元/股
【交银国际:下调药明生物目标价至12.3港元 业绩短期承压】金十数据8月23日讯,交银国际发表研究报告,下调药明生物(02269.
美港电讯 · 08-23 11:18
【交银国际:下调药明生物目标价至12.3港元 业绩短期承压】金十数据8月23日讯,交银国际发表研究报告,下调药明生物(02269.
研报掘金|招商证券:下调药明生物目标价至10港元 评级“持有”
格隆汇 · 08-23 11:11
研报掘金|招商证券:下调药明生物目标价至10港元 评级“持有”
《大行》瑞银降药明生物(02269.HK)目标价至11.5元 业绩显示需求复苏不明朗
阿斯达克财经 · 08-23 10:19
《大行》瑞银降药明生物(02269.HK)目标价至11.5元 业绩显示需求复苏不明朗
《大行》招商证券降药明生物(02269.HK)目标价至10元 新增项目较预期少
阿斯达克财经 · 08-23 09:43
《大行》招商证券降药明生物(02269.HK)目标价至10元 新增项目较预期少
【券商聚焦】交银国际削药明生物(02269)目标价24% 指业绩符预期但短期不确定性仍存
金吾财讯 · 08-23 08:55
【券商聚焦】交银国际削药明生物(02269)目标价24% 指业绩符预期但短期不确定性仍存
药明生物(02269):新增项目超预期,基本面稳健中长期发展核心逻辑未变
智通财经 · 08-22 21:38
药明生物(02269):新增项目超预期,基本面稳健中长期发展核心逻辑未变
再跌8%股价已成“渣”!药明生物的业绩究竟如何?
财华社 · 08-22 18:48
再跌8%股价已成“渣”!药明生物的业绩究竟如何?
南向资金今日净卖出0.83亿元。港股通(沪)方面,小米集团-W、腾讯控股分别获净卖出9.65亿港元、1.06亿港元;石药集团净买入额居首,金额为3.
美港电讯 · 08-22 17:45
南向资金今日净卖出0.83亿元。港股通(沪)方面,小米集团-W、腾讯控股分别获净卖出9.65亿港元、1.06亿港元;石药集团净买入额居首,金额为3.
8月22日港股通(深)十大成交股:石药集团净买入居首,药明生物净卖出第一
证券之星 · 08-22 17:40
8月22日港股通(深)十大成交股:石药集团净买入居首,药明生物净卖出第一
更新版 1-中港股市:沪综指连三日收跌创六个半月新低,恒指收高1.4%科技股领涨
Reuters · 08-22 16:27
更新版 1-中港股市:沪综指连三日收跌创六个半月新低,恒指收高1.4%科技股领涨
港股三大指数午后走强 恒指全日收涨1.44% 小米集团(01810)升9.02%
金吾财讯 · 08-22 16:22
港股三大指数午后走强 恒指全日收涨1.44% 小米集团(01810)升9.02%
药明生物08月22日遭主力大幅抛售1.10亿元 环比增加168.97%
市场透视 · 08-22 16:15
药明生物08月22日遭主力大幅抛售1.10亿元 环比增加168.97%
药明生物(02269)出现大手卖出54.95万股,成交价$10.44,涉资573.678万
阿斯达克财经 · 08-22 13:34
药明生物(02269)出现大手卖出54.95万股,成交价$10.44,涉资573.678万
药明生物上半年净利降逾三成,不派息!股价创7年新低
格隆汇 · 08-22 12:19
药明生物上半年净利降逾三成,不派息!股价创7年新低
港股异动丨药明生物跌超8%创7年新低,上半年净利下滑33.9%,不派息
格隆汇 · 08-22 11:53
港股异动丨药明生物跌超8%创7年新低,上半年净利下滑33.9%,不派息
【港股通】药明生物(02269)跌超7.5% 中期纯利下跌33.9%
金吾财讯 · 08-22 10:38
【港股通】药明生物(02269)跌超7.5% 中期纯利下跌33.9%
药明生物(02269)股价下跌8.275%,现价港币$10.42
阿斯达克财经 · 08-22 10:28
药明生物(02269)股价下跌8.275%,现价港币$10.42
暂无数据
公司概况
公司名称:
药明生物
所属市场:
SEHK
上市日期:
--
主营业务:
药明生物技术有限公司是一家主要提供生物制剂发现、开发及生产服务的投资控股公司。该公司的技术平台包括WuXiBody TM双特异抗体技术平台及抗体偶联药物(ADC)技术平台等。其引入多个新项目至研发管线。该公司有疫苗生产基地,为客户生产疫苗以供应全球市场。该公司于中国市场及北美,欧洲和其他海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":10.26,"timestamp":1724400507029,"preClose":10.4,"halted":0,"volume":48564362,"delay":0,"floatShares":4153282399,"shares":4153282399,"eps":0.89479387,"marketStatus":"休市中","marketStatusCode":7,"change":-0.14,"latestTime":"08-23 16:08:27","open":10.24,"high":10.56,"low":10.16,"amount":502754135,"amplitude":0.038462,"askPrice":10.26,"askSize":887500,"bidPrice":10.24,"bidSize":148500,"shortable":3,"etf":0,"ttmEps":0.657375385419022,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"listingDate":1497283200000,"adjPreClose":10.4,"adrRate":0,"openAndCloseTimeList":[[1724376600000,1724385600000],[1724389200000,1724400000000]],"volumeRatio":0.7055106839323427,"optionData":{"bulkOrders":[{"symbol":"WXB.HK","call":true,"expireDate":1724860800000,"strike":"10.50","timestamp":1724377080928,"price":0.28999999165534973,"volume":573,"amount":83085,"type":"*"},{"symbol":"WXB.HK","call":false,"expireDate":1750953600000,"strike":"11.00","timestamp":1724377452335,"price":2.0799999237060547,"volume":500,"amount":520000,"type":"*"}]},"impliedVol":0.519,"impliedVolPercentile":0.3266,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK"},"requestUrl":"/m/hq/s/02269/tweets","defaultTab":"tweets","newsList":[{"id":"2461555926","title":"药明生物:未完成订单201亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461555926","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461555926?lang=zh_cn&edition=full","pubTime":"2024-08-23 15:56","pubTimestamp":1724399771,"startTime":"0","endTime":"0","summary":"近日,CXO领军企业药明生物半年报出炉,2024年上半年,公司整体营业收入85.7亿元,同比增长1%。此外,财报还显示,药明生物未完成订单201.1亿美元。截至2024年6月30日,3年内的未完成订单金额超过36亿美元,为近期收入机会提供了很大机会。根据最新消息,美国众议院可能于下月对《生物安全法案》投票。药明生物表示,如果该法案通过,它可能会影响美国政府资助的项目。公司目前正在与客户合作,以减轻《生物安全法》的潜在影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082316172195b752e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082316172195b752e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002463.SGD","IE00B0JY6N72.USD","LU0456846285.SGD","LU0819121731.USD","LU0856984785.SGD","LU0307460666.USD","LU0823426308.USD","LU0979878070.USD","LU0348825331.USD","LU1794554557.SGD","LU0516422440.USD","LU0708995583.HKD","LU2039709279.SGD","LU0823426480.USD","LU0359201612.USD","LU1242518857.USD","LU0051755006.USD","LU1688375341.USD","BK1589","LU1242518931.SGD","LU0043850808.USD","LU0516422366.SGD","02269","LU0516423174.USD","BK1576","BK1521","LU0359202008.SGD","LU0516422952.EUR","LU0516423091.SGD","LU1880383366.USD","BK1141","LU0320764599.SGD","LU0327786744.USD","LU0417516738.SGD","SG9999002562.SGD","LU0572944931.SGD","LU0039217434.USD","LU0181495838.USD","LU1720050803.USD","LU0417516902.SGD","LU0456827905.SGD","LU0326950275.SGD","BK1610","LU0140636845.USD","LU0052750758.USD","LU0588546209.SGD","LU0348735423.USD"],"gpt_icon":1},{"id":"2461646556","title":"又一家企业新增订单数超预期,医药CXO行业再次释放积极信号","url":"https://stock-news.laohu8.com/highlight/detail?id=2461646556","media":"中国制药网","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461646556?lang=zh_cn&edition=full","pubTime":"2024-08-23 15:42","pubTimestamp":1724398955,"startTime":"0","endTime":"0","summary":"有分析人士指出,随着全球医药市场需求的持续增长、国内医药创新政策的不断优化以及 CXO 企业自身能力的提升,中国CXO行业有望迎来更加稳健的发展。据悉,随着药企半年报的集中披露,不少CXO企业业绩增长出现放缓。如作为CXO行业企业之一的 药明生物 近期半年报数据展现了诸多亮点,也在释放行业积极信号。分析人士表示,2024年上半年我国CXO行业业绩表现分化。展望未来,中国CXO行业有望迎来更加稳健的发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082315510695b733ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082315510695b733ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1720050803.USD","09939","LU0516422952.EUR","LU1880383366.USD","02269","LU1688375341.USD","LU0823426480.USD","LU0516423091.SGD","LU0051755006.USD","LU0516422366.SGD","LU0348735423.USD","LU0359201612.USD","LU0052750758.USD","LU0320764599.SGD","LU0327786744.USD","BK1521","BK1574","LU0708995583.HKD","LU2039709279.SGD","LU0348825331.USD","LU0588546209.SGD","BK1610","IE00B0JY6N72.USD","LU0856984785.SGD","SG9999002562.SGD","BK1161","LU0516423174.USD","LU0417516738.SGD","LU0572944931.SGD","LU0823426308.USD","BK1515","LU0326950275.SGD","LU0181495838.USD","LU0359202008.SGD","LU0979878070.USD","BK1141","LU1242518857.USD","LU1242518931.SGD","LU0140636845.USD","LU0039217434.USD","BK1576","SG9999002463.SGD","LU0456827905.SGD","LU0307460666.USD","LU1794554557.SGD","LU0417516902.SGD","BK1589","LU0819121731.USD","LU0456846285.SGD","LU0043850808.USD"],"gpt_icon":1},{"id":"2461375305","title":"药明生物(02269)下跌2.12%,报10.18元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2461375305","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461375305?lang=zh_cn&edition=full","pubTime":"2024-08-23 14:45","pubTimestamp":1724395517,"startTime":"0","endTime":"0","summary":"8月23日,药明生物(02269)盘中下跌2.12%,截至14:45,报10.18元/股,成交3.94亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商,提供全面、综合及高度定制的服务,包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额,已与全球20大制药公司中的12家建立合作关系。截至2024年中报,药明生物营业总收入85.74亿元、净利润14.99亿元。8月21日,2024财年中报归属股东应占溢利14.99亿人民币,同比下降33.86%,基本每股收益0.37人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/23144542646988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0359201612.USD","LU0307460666.USD","BK1141","BK1521","LU0052750758.USD","LU0516423091.SGD","LU0823426480.USD","LU0516423174.USD","LU0708995583.HKD","BK1589","LU0856984785.SGD","LU0359202008.SGD","LU1794554557.SGD","LU2039709279.SGD","SG9999002463.SGD","LU0320764599.SGD","LU0588546209.SGD","02269","LU0039217434.USD","LU0181495838.USD","BK1610","IE00B0JY6N72.USD","LU0051755006.USD","LU0043850808.USD","LU0516422366.SGD","LU0516422440.USD","LU0516422952.EUR","LU1720050803.USD","LU1242518931.SGD","LU0326950275.SGD","LU0823426308.USD","LU0819121731.USD","LU0572944931.SGD","LU0456846285.SGD","BK1576","SG9999002562.SGD","LU0456827905.SGD","LU0140636845.USD","LU1242518857.USD","LU0417516902.SGD","LU0327786744.USD","LU0348735423.USD","LU0348825331.USD","LU1880383366.USD","LU0979878070.USD","LU0417516738.SGD","LU1688375341.USD"],"gpt_icon":1},{"id":"2461147589","title":"【交银国际:下调药明生物目标价至12.3港元 业绩短期承压】金十数据8月23日讯,交银国际发表研究报告,下调药明生物(02269.","url":"https://stock-news.laohu8.com/highlight/detail?id=2461147589","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461147589?lang=zh_cn&edition=full","pubTime":"2024-08-23 11:18","pubTimestamp":1724383086,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1242518857.USD","LU1720050803.USD","LU0359202008.SGD","LU0456827905.SGD","LU0516423091.SGD","LU0588546209.SGD","LU0823426480.USD","BK1521","LU0417516902.SGD","LU0572944931.SGD","LU0456846285.SGD","02269","LU0417516738.SGD","LU0823426308.USD","LU0516422440.USD","BK1141","LU0039217434.USD","LU0326950275.SGD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0516423174.USD","LU2039709279.SGD","LU0052750758.USD","BK1576","LU0320764599.SGD","LU1242518931.SGD","LU1688375341.USD","LU0348735423.USD","LU0327786744.USD","LU0516422366.SGD","BK1589","LU0051755006.USD","LU0979878070.USD","LU0359201612.USD","LU1880383366.USD","LU0181495838.USD","BK1610","LU0516422952.EUR","SG9999002562.SGD","LU0043850808.USD","LU0140636845.USD","LU0819121731.USD","LU0348825331.USD","SG9999002463.SGD","LU0856984785.SGD","LU1794554557.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2461816095","title":"研报掘金|招商证券:下调药明生物目标价至10港元 评级“持有”","url":"https://stock-news.laohu8.com/highlight/detail?id=2461816095","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461816095?lang=zh_cn&edition=full","pubTime":"2024-08-23 11:11","pubTimestamp":1724382717,"startTime":"0","endTime":"0","summary":"招商证券发表报告指,药明生物上半年营业额按年增长1%,符合预期;经调整净利按年跌26.5%,差过该行和市场预期。报告指,药明生物维持2024财年指引,即营业额按年增长5至10%,意味着下半年按年增长9至19%,考虑到不利因素,该行认为具挑战性。招商证券指,基于未交付订单(backlog)疲弱、新增项目低于预期,以及XDC少数股东权益摊薄效应,将药明生物目标价由13港元下调至10港元,评级“持有”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823111158ab5f3f17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823111158ab5f3f17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02269","06099"],"gpt_icon":1},{"id":"2461585190","title":"《大行》瑞银降药明生物(02269.HK)目标价至11.5元 业绩显示需求复苏不明朗","url":"https://stock-news.laohu8.com/highlight/detail?id=2461585190","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461585190?lang=zh_cn&edition=full","pubTime":"2024-08-23 10:19","pubTimestamp":1724379540,"startTime":"0","endTime":"0","summary":"瑞银发表研究报告指,药明生物上半年收入及纯利均大致逊于该行及市场预期。虽然管理层维持其2024年收入按年增5至10%的目标,并相信下半年增长将高于上半年,但该行认为,公司业绩显示需求复苏并不明朗。该行将集团目标价由16.6元下调至11.5元,维持“中性”评级。瑞银下调集团2024至26年的收入预测0.9%、7.1%及11.7%,2024年毛利率预测降1.4个百分点,而2026年的预测则升1.5个百分点。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190319115856757_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190319115856757_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1374428/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02269"],"gpt_icon":1},{"id":"2461300223","title":"《大行》招商证券降药明生物(02269.HK)目标价至10元 新增项目较预期少","url":"https://stock-news.laohu8.com/highlight/detail?id=2461300223","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461300223?lang=zh_cn&edition=full","pubTime":"2024-08-23 09:43","pubTimestamp":1724377380,"startTime":"0","endTime":"0","summary":"招商证券发表报告指,药明生物(02269.HK) 上半年营业额按年增长1%,符合预期;经调整净利按年跌26.5%,差过该行和市场预期。报告指,药明生物维持2024财年指引,即营业额按年增长5至10%,意味着下半年按年增长9至19%,考虑到不利因素,该行认为具挑战性。招商证券指,基于未交付订单(backlog)疲弱、新增项目低于预期,以及XDC少数股东权益摊薄效应,将药明生物目标价由13元下调至10元。评级“持有”。(ha/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-08-22 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190604131534109_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190604131534109_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1374388/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02269","06099"],"gpt_icon":1},{"id":"2461301207","title":"【券商聚焦】交银国际削药明生物(02269)目标价24% 指业绩符预期但短期不确定性仍存","url":"https://stock-news.laohu8.com/highlight/detail?id=2461301207","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461301207?lang=zh_cn&edition=full","pubTime":"2024-08-23 08:55","pubTimestamp":1724374517,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发研报指,药明生物 1H24收入同比增长1.0%,剔除新冠增长7.7%,大致符合此前公司的指引。经调整净利润同比下滑20.7%。该行指,公司1H24收入基本符合预期,新签后期订单数量表现较好,但行业景气度波动和外部环境变化依旧是短期业绩最大的不确定因素。该行下调公司2024-26年盈利预测4-19%,下调DCF目标价至12.3港元,维持中性评级。","market":"other","thumbnail":"https://static.szfiu.com/news/20200915/NDVmZWE2ZWUwNjY0MTYwMDE0OTY1ODIwOA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NDVmZWE2ZWUwNjY0MTYwMDE0OTY1ODIwOA==.png"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1942861","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"gpt_icon":1},{"id":"2461310130","title":"药明生物(02269):新增项目超预期,基本面稳健中长期发展核心逻辑未变","url":"https://stock-news.laohu8.com/highlight/detail?id=2461310130","media":"智通财经","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461310130?lang=zh_cn&edition=full","pubTime":"2024-08-22 21:38","pubTimestamp":1724333931,"startTime":"0","endTime":"0","summary":"从关键财务指标可见,药明生物目前基本面依旧稳健,而这也从侧面印证了公司CRDMO商业模式以及“跟随并赢得分子”战略在推动长期可持续方面的重要作用。在质量管理方面,目前药明生物共接受EMA和FDA 21次检查,100%成功通过PAI。目前,药明生物爱尔兰基地2025年已接近满产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1168927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999002463.SGD","LU0856984785.SGD","BK1610","LU0516422440.USD","LU1242518931.SGD","LU0181495838.USD","LU0039217434.USD","BK1576","LU0359202008.SGD","LU1242518857.USD","LU0417516738.SGD","LU2039709279.SGD","LU0456827905.SGD","LU0326950275.SGD","IE00B0JY6N72.USD","LU1688375341.USD","LU0456846285.SGD","LU0516423091.SGD","LU0516423174.USD","LU0979878070.USD","LU0320764599.SGD","BK1141","LU0359201612.USD","LU0516422952.EUR","LU0052750758.USD","LU0348735423.USD","LU0823426308.USD","LU0327786744.USD","LU0348825331.USD","LU0819121731.USD","LU1794554557.SGD","LU0572944931.SGD","SG9999002562.SGD","02269","BK1521","BK1589","LU0588546209.SGD","LU0417516902.SGD","LU0516422366.SGD","LU0051755006.USD","LU1720050803.USD","LU0043850808.USD","LU0140636845.USD","LU0708995583.HKD","LU1880383366.USD","LU0823426480.USD","LU0307460666.USD"],"gpt_icon":1},{"id":"2461161392","title":"再跌8%股价已成“渣”!药明生物的业绩究竟如何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2461161392","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461161392?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:48","pubTimestamp":1724323718,"startTime":"0","endTime":"0","summary":"8月22日,在港上市的医药外包概念股迎来普跌,康龙化成(03759.HK)、凯莱英(06821.HK)等个股遭遇下挫,泰格医药(03347.HK)跌逾5%。更关键的是,行业龙头药明生物(02269.HK)放量跳空大跌了8.45%,创2017年8月以来新低,仅在2024年就累跌近65%,相当惨烈。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202408_1/58ef2b40-3452-4ed2-bb4c-07e30bb747cc.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202408_1/58ef2b40-3452-4ed2-bb4c-07e30bb747cc.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/66c7178653243c46f4c8e704","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["LU0456827905.SGD","LU0417516738.SGD","LU0326950275.SGD","LU0052750758.USD","SG9999002562.SGD","LU0043850808.USD","LU0327786744.USD","BK1589","BK1576","LU0348735423.USD","LU1242518857.USD","SG9999002463.SGD","LU0051755006.USD","LU0140636845.USD","IE00B0JY6N72.USD","LU0588546209.SGD","LU1720050803.USD","LU0307460666.USD","LU1242518931.SGD","BK1521","LU0823426308.USD","LU1880383366.USD","LU1794554557.SGD","LU0348825331.USD","LU0572944931.SGD","LU0819121731.USD","LU0823426480.USD","LU0320764599.SGD","LU0039217434.USD","02269","LU0359201612.USD","LU0359202008.SGD","LU0708995583.HKD","LU0516423091.SGD","LU0516422952.EUR","LU0417516902.SGD","LU0979878070.USD","LU1688375341.USD","LU0516423174.USD","BK1610","LU0516422366.SGD","LU2039709279.SGD","LU0456846285.SGD","LU0181495838.USD","LU0516422440.USD","BK1141","LU0856984785.SGD"],"gpt_icon":1},{"id":"2461239512","title":"南向资金今日净卖出0.83亿元。港股通(沪)方面,小米集团-W、腾讯控股分别获净卖出9.65亿港元、1.06亿港元;石药集团净买入额居首,金额为3.","url":"https://stock-news.laohu8.com/highlight/detail?id=2461239512","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461239512?lang=zh_cn&edition=full","pubTime":"2024-08-22 17:45","pubTimestamp":1724319912,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["YANG","HSTECH","IE0003795394.USD","LU1242518931.SGD","07226","LU0181495838.USD","IE0034224299.USD","00700","81810","LU0359202008.SGD","LU0417516738.SGD","LU0106259558.USD","IE0003895053.USD","IE00B29SXG58.USD","HK0000306701.USD","LU0067412154.USD","LU0516423091.SGD","IE00BPRC5H50.USD","01093","LU1807302812.USD","XIACY","LU0029874905.USD","LU1226287529.USD","IE00B97KM107.HKD","LU0011963245.USD","IE00B8HQ1Z84.USD","LU0327786744.USD","LU0501845795.SGD","IE0031814852.USD","LU1794554557.SGD","LU0049853897.USD","HSCEI","02269","IE0003851619.USD","LU0588546209.SGD","LU0072913022.USD","01810","LU0516422366.SGD","IE0032431581.USD","80700","BK1506","HK0000306685.HKD","IE00B067MR52.USD","LU0047713382.USD","LU0048580855.USD","LU0708995583.HKD","LU1008478684.HKD","LU1880383366.USD","IE00B8L5B284.USD","LU0307460666.USD"],"gpt_icon":0},{"id":"2461339544","title":"8月22日港股通(深)十大成交股:石药集团净买入居首,药明生物净卖出第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2461339544","media":"证券之星","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461339544?lang=zh_cn&edition=full","pubTime":"2024-08-22 17:40","pubTimestamp":1724319632,"startTime":"0","endTime":"0","summary":"证券之星消息,8月22日,恒生指数涨1.44%,报收17641.0点。当日南向资金净卖出0.83亿港元,交易所公布的港股通(深)十大成交股中,净买入个股共1只,净买入金额最多的是石药集团,净买入9184.78万港元,净卖出个股共9只,净卖出金额最多的是药明生物,净卖出3.74亿港元。详情可见下表:以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200032540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0456827905.SGD","IE00B031HY20.USD","LU0326950275.SGD","IE00B5MMRT66.SGD","SG9999002562.SGD","LU0327786744.USD","BK1576","LU0348735423.USD","LU1242518857.USD","SG9999004220.SGD","IE00B543WZ88.USD","LU0140636845.USD","IE00B0JY6N72.USD","LU0588546209.SGD","HSTECH","LU0307460666.USD","LU0880133367.SGD","LU1720050803.USD","LU1242518931.SGD","LU1880383366.USD","IE0008368742.USD","LU0348825331.USD","LU0572944931.SGD","LU0819121731.USD","LU0823426480.USD","LU0320764599.SGD","LU0039217434.USD","01093","LU1807302812.USD","02269","LU1226287529.USD","HSCEI","LU0708995583.HKD","LU0359202008.SGD","BK1515","LU0516422952.EUR","LU0516423091.SGD","LU0417516902.SGD","LU1688375341.USD","LU0516423174.USD","BK1610","LU0516422366.SGD","LU2039709279.SGD","BK1191","LU0456846285.SGD","LU1152091168.USD","LU0516422440.USD","BK1141","LU0856984785.SGD"],"gpt_icon":1},{"id":"2461929364","title":"更新版 1-中港股市:沪综指连三日收跌创六个半月新低,恒指收高1.4%科技股领涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2461929364","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461929364?lang=zh_cn&edition=full","pubTime":"2024-08-22 16:27","pubTimestamp":1724315277,"startTime":"0","endTime":"0","summary":" 路透上海8月22日 - 中国股市沪综指周四连续第三个交易日收跌,创六个半月新低,继续盘整走势,A股游戏板块领跌;香港恒生指数则收高1.4%,科技板块领涨,业绩超预期的小米 劲升。沪综指 收跌0.3%至2,848.77点,前次收盘低位为2月7日的2,829.7点;沪深300指数 亦收低0.3%。香港恒生指数 收盘升1.4%至17,641点;恒生科技指数 收高2.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU2039709279.SGD","BK1576","LU0348735423.USD","BIDU","BK1193","LU0348825331.USD","LU2097828631.EUR","LU0326950275.SGD","LU0359202008.SGD","LU0456827905.SGD","LU0327786744.USD","LU0039217434.USD","LU1880383366.USD","LU0823426480.USD","LU1242518857.USD","LU0516422440.USD","LU0516422952.EUR","LU0043850808.USD","LU0516423091.SGD","BK1506","BK1502","IE00B0JY6N72.USD","LU0181495838.USD","LU0823426308.USD","XPEV","BK1141","LU0516422366.SGD","SG9999002562.SGD","LU1794554557.SGD","BK1610","LU0588546209.SGD","BK1575","399300","LU0856984785.SGD","159982","LU1242518931.SGD","LU2097828557.USD","LU0320764599.SGD","LU0819121731.USD","LU0572944931.SGD","81810","LU0516423174.USD","LU1688375341.USD","02269","LU0417516902.SGD","01810","LU0140636845.USD","LU0307460666.USD","LU1720050803.USD","LU0708995583.HKD"],"gpt_icon":1},{"id":"2461364757","title":"港股三大指数午后走强 恒指全日收涨1.44% 小米集团(01810)升9.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461364757","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461364757?lang=zh_cn&edition=full","pubTime":"2024-08-22 16:22","pubTimestamp":1724314977,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数午后走强,截至收盘,恒指涨1.44%,国企指数涨1.34%,恒生科技指数涨2.16%。此外,日前公司发盈喜,预计预计于上半年将取得净利润约人民币5.5亿元至人民币6亿元,同比增加约180%至205%。公司截至2024年6月30日止六个月中期股东应占溢利30.2亿元,同比增长1.80%,每股基本盈利25.51分。期内,集团收入162.84亿元,同比增长1.27%。受肿瘤药物销售所拖累,第二季成品药收入按年跌8%至60亿元人民币。","market":"other","thumbnail":"https://static.szfiu.com/news/20200908/OWI2MjQ4MTk0NTQw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/OWI2MjQ4MTk0NTQw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1942844","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU0072462343.USD","HSImain","LU0979878070.USD","LU0251143458.SGD","02833","BK1523","LU0819121731.USD","SG9999002562.SGD","SG9999004220.SGD","02269","513600","MCHmain","BK1141","HSCEI","IE00BKZH1Z71.USD","IE0008368742.USD","HHImain","IE00B8HQ1Z84.USD","IE0003795394.USD","IE0003851619.USD","LU1242518931.SGD","YANG","AAGIY","LU0048580855.USD","LU0029875118.USD","81299","HSTECH","LU0140636845.USD","LU1794554557.SGD","01810","LU0164880469.USD","81810","BK1506","LU0326950275.SGD","02318","00960","LU0067412154.USD","MHImain","01093","IE0031814852.USD","LU1807302812.USD","LU0048597586.USD","LU0165289439.USD","LU0348825331.USD","00316","BK1610","01299","HSI"],"gpt_icon":1},{"id":"2461361011","title":"药明生物08月22日遭主力大幅抛售1.10亿元 环比增加168.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461361011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461361011?lang=zh_cn&edition=full","pubTime":"2024-08-22 16:15","pubTimestamp":1724314554,"startTime":"0","endTime":"0","summary":"08月22日, 药明生物股价跌8.45%,报收10.40元,成交金额18.87亿元,换手率4.34%,振幅7.57%,量比4.85。药明生物今日主力资金净流出1.10亿元,上一交易日主力净流出4083万元,今日环比增加168.97%。该股近5个交易日下跌7.43%,主力资金累计净流出6087万元;近20日主力资金累计净流入2.18亿元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082216170695b343af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082216170695b343af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1242518857.USD","LU1720050803.USD","LU0359202008.SGD","LU0456827905.SGD","LU0516423091.SGD","LU0588546209.SGD","LU0823426480.USD","BK1521","LU0417516902.SGD","LU0572944931.SGD","LU0456846285.SGD","02269","LU0417516738.SGD","LU0823426308.USD","LU0516422440.USD","BK1141","LU0039217434.USD","LU0326950275.SGD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0516423174.USD","LU2039709279.SGD","LU0052750758.USD","BK1576","LU0320764599.SGD","LU1242518931.SGD","LU1688375341.USD","LU0348735423.USD","LU0327786744.USD","LU0516422366.SGD","BK1589","LU0051755006.USD","LU0979878070.USD","LU0359201612.USD","LU1880383366.USD","LU0181495838.USD","BK1610","LU0516422952.EUR","SG9999002562.SGD","LU0043850808.USD","LU0140636845.USD","LU0819121731.USD","LU0348825331.USD","SG9999002463.SGD","LU0856984785.SGD","LU1794554557.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2461359285","title":"药明生物(02269)出现大手卖出54.95万股,成交价$10.44,涉资573.678万","url":"https://stock-news.laohu8.com/highlight/detail?id=2461359285","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461359285?lang=zh_cn&edition=full","pubTime":"2024-08-22 13:34","pubTimestamp":1724304840,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在下午01:34出现大手卖出,成交量为54.95万,成交价为港币$10.44,涉资573.678万。至目前为止,股价跌7.923%,今日最高价为$11.0,而最低价为$10.42,总成交量为1.044亿股,总成交金额港币$11.076亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2408223887/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0348735423.USD","LU2039709279.SGD","LU0359201612.USD","LU0043850808.USD","LU0140636845.USD","BK1521","LU0326950275.SGD","LU0359202008.SGD","LU0572944931.SGD","LU0588546209.SGD","LU0979878070.USD","LU1688375341.USD","LU0856984785.SGD","LU0417516738.SGD","02269","LU0516422952.EUR","LU1242518857.USD","LU1794554557.SGD","SG9999002463.SGD","LU0516422366.SGD","LU0307460666.USD","LU0456846285.SGD","LU0516422440.USD","BK1589","LU0327786744.USD","LU1242518931.SGD","LU0051755006.USD","LU1880383366.USD","LU0516423091.SGD","LU0417516902.SGD","LU0708995583.HKD","BK1576","LU0819121731.USD","IE00B0JY6N72.USD","LU0039217434.USD","LU0052750758.USD","LU0348825331.USD","LU0181495838.USD","BK1610","LU0823426480.USD","LU1720050803.USD","LU0823426308.USD","LU0516423174.USD","LU0456827905.SGD","SG9999002562.SGD","BK1141","LU0320764599.SGD"],"gpt_icon":0},{"id":"2461330633","title":"药明生物上半年净利降逾三成,不派息!股价创7年新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2461330633","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461330633?lang=zh_cn&edition=full","pubTime":"2024-08-22 12:19","pubTimestamp":1724300393,"startTime":"0","endTime":"0","summary":"维持2024全年指引不变","market":"hk","thumbnail":"https://img3.gelonghui.com/c5097-cc6163ca-b52d-474c-ae19-2fd44b9f1a3d.jpg?guru_height=853&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/c5097-cc6163ca-b52d-474c-ae19-2fd44b9f1a3d.jpg?guru_height=853&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/945580","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0516422440.USD","LU0043850808.USD","LU0516422952.EUR","LU1242518857.USD","02269","LU0359201612.USD","BK1589","LU0052750758.USD","LU0823426308.USD","LU1688375341.USD","SG9999002463.SGD","LU0307460666.USD","BK1521","LU0039217434.USD","LU0051755006.USD","LU0572944931.SGD","LU0516423174.USD","BK1610","LU0327786744.USD","LU1794554557.SGD","LU0979878070.USD","LU0588546209.SGD","LU0140636845.USD","LU0320764599.SGD","LU0326950275.SGD","LU0348735423.USD","LU0348825331.USD","LU0456846285.SGD","LU0181495838.USD","LU0856984785.SGD","LU0456827905.SGD","LU0708995583.HKD","LU1720050803.USD","BK1141","LU1880383366.USD","LU2039709279.SGD","LU0417516902.SGD","LU0516422366.SGD","SG9999002562.SGD","LU0417516738.SGD","LU0823426480.USD","LU0359202008.SGD","LU0516423091.SGD","BK1576","IE00B0JY6N72.USD","LU0819121731.USD","LU1242518931.SGD"],"gpt_icon":0},{"id":"2461333220","title":"港股异动丨药明生物跌超8%创7年新低,上半年净利下滑33.9%,不派息","url":"https://stock-news.laohu8.com/highlight/detail?id=2461333220","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461333220?lang=zh_cn&edition=full","pubTime":"2024-08-22 11:53","pubTimestamp":1724298797,"startTime":"0","endTime":"0","summary":"格隆汇8月22日|药明生物盘中跌超8%至10.42港元,股价创2017年8月以来新低,市值跌至432.7亿港元;该股曾于2021年7月创出148港元的历史最高价。每股基本盈利为0.37元,同比减少32.7%。董事会决定不派发中期股息。药明生物上半年毛利率由41.9%跌2.8个百分点至39.1%,因来自发现服务减少的影 响,以及新冠项目取消,上半年中国的工厂利用率略低于去年同期。药明来自北美的收入增28%至50.1亿元,但来自中国及欧洲的收入分别下跌21%及27%,至14.2亿及18.6亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082211532795b27e3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082211532795b27e3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1521","LU0348735423.USD","LU0819121731.USD","LU0348825331.USD","LU0823426480.USD","LU1688375341.USD","02269","LU0572944931.SGD","LU0326950275.SGD","LU1720050803.USD","SG9999002463.SGD","LU0456827905.SGD","BK1589","LU1794554557.SGD","LU0359201612.USD","LU0359202008.SGD","LU0516422440.USD","BK1576","LU0043850808.USD","LU0417516902.SGD","LU0516422366.SGD","LU0320764599.SGD","LU1242518931.SGD","LU1880383366.USD","LU0327786744.USD","LU0140636845.USD","LU0181495838.USD","LU0051755006.USD","LU0307460666.USD","LU0856984785.SGD","LU0516422952.EUR","LU0052750758.USD","LU0417516738.SGD","LU1242518857.USD","LU0516423091.SGD","SG9999002562.SGD","BK1610","LU0588546209.SGD","LU0039217434.USD","LU0979878070.USD","LU0516423174.USD","LU0456846285.SGD","BK1141","LU0823426308.USD","IE00B0JY6N72.USD","LU0708995583.HKD","LU2039709279.SGD"],"gpt_icon":0},{"id":"2461336968","title":"【港股通】药明生物(02269)跌超7.5% 中期纯利下跌33.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461336968","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461336968?lang=zh_cn&edition=full","pubTime":"2024-08-22 10:38","pubTimestamp":1724294312,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明生物(02269)早盘股价持续受压,截至发稿,报10.5港元,跌7.57%,成交额6.21亿港元。公司发布中期业绩,截至6月30日止未经审核之中期纯利14.99亿元(人民币,下同),同比跌33.9%,每股盈利37分,不派中期息。期内收益85.74亿元,同比升1%;毛利33.5亿元,同比跌5.9%;毛利率39.1%,同比跌2.8个百分点;除税前溢利20.08亿元,同比跌20.6%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/ODEyMDM1NzM2NTU5NjM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ODEyMDM1NzM2NTU5NjM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1942803","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU0359201612.USD","LU2039709279.SGD","BK1576","LU0348735423.USD","SG9999002463.SGD","LU0348825331.USD","BK1521","LU0979878070.USD","LU0326950275.SGD","HSCEI","LU0359202008.SGD","LU0456827905.SGD","LU0327786744.USD","LU0039217434.USD","LU1880383366.USD","LU0823426480.USD","LU1242518857.USD","LU0516422440.USD","LU0516422952.EUR","LU0043850808.USD","LU0516423091.SGD","LU0051755006.USD","IE00B0JY6N72.USD","LU0181495838.USD","LU0823426308.USD","BK1141","LU0516422366.SGD","SG9999002562.SGD","LU1794554557.SGD","BK1610","LU0588546209.SGD","YANG","LU0856984785.SGD","LU1242518931.SGD","LU0320764599.SGD","LU0819121731.USD","LU0572944931.SGD","LU0516423174.USD","HSTECH","LU0417516738.SGD","LU1688375341.USD","02269","LU0052750758.USD","LU0417516902.SGD","LU0140636845.USD","LU0307460666.USD","LU1720050803.USD","LU0708995583.HKD"],"gpt_icon":1},{"id":"2461336678","title":"药明生物(02269)股价下跌8.275%,现价港币$10.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2461336678","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461336678?lang=zh_cn&edition=full","pubTime":"2024-08-22 10:28","pubTimestamp":1724293680,"startTime":"0","endTime":"0","summary":"[下跌股]药明生物(02269) 股价在上午10:28比前收市价下跌8.275%,现股价为港币$10.42。至目前为止,今日最高价为$11.0,而最低价为$10.42。总成交量为5.977千万股,总成交金额为港币$6.393亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240822711/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1794554557.SGD","LU0327786744.USD","LU0051755006.USD","LU0417516902.SGD","LU0456827905.SGD","LU0348735423.USD","LU0307460666.USD","LU0979878070.USD","LU0359201612.USD","LU0856984785.SGD","LU0043850808.USD","IE00B0JY6N72.USD","BK1141","LU0359202008.SGD","LU0039217434.USD","LU0516422440.USD","LU1688375341.USD","LU1720050803.USD","LU1242518857.USD","LU0823426308.USD","LU0181495838.USD","LU0823426480.USD","LU0708995583.HKD","LU0516423091.SGD","LU0417516738.SGD","BK1610","LU1242518931.SGD","LU0516422952.EUR","LU0140636845.USD","LU0588546209.SGD","LU0819121731.USD","LU0572944931.SGD","LU0326950275.SGD","LU0052750758.USD","LU0456846285.SGD","02269","LU0516422366.SGD","LU2039709279.SGD","BK1576","SG9999002463.SGD","SG9999002562.SGD","BK1521","LU0516423174.USD","LU0348825331.USD","LU0320764599.SGD","LU1880383366.USD","BK1589"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":-0.1276},{"period":"1month","weight":-0.05},{"period":"3month","weight":-0.1752},{"period":"6month","weight":-0.4375},{"period":"1year","weight":-0.77},{"period":"ytd","weight":-0.6534}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.0174},{"period":"3month","weight":-0.0536},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0329},{"period":"ytd","weight":0.0331}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明生物技术有限公司是一家主要提供生物制剂发现、开发及生产服务的投资控股公司。该公司的技术平台包括WuXiBody TM双特异抗体技术平台及抗体偶联药物(ADC)技术平台等。其引入多个新项目至研发管线。该公司有疫苗生产基地,为客户生产疫苗以供应全球市场。该公司于中国市场及北美,欧洲和其他海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.035713},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.034807},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.00624},{"month":4,"riseRate":0.428571,"avgChangeRate":0.021731},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.011574},{"month":6,"riseRate":0.571429,"avgChangeRate":0.069801},{"month":7,"riseRate":0.625,"avgChangeRate":0.059733},{"month":8,"riseRate":0.5,"avgChangeRate":0.019735},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.041003},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.017109},{"month":11,"riseRate":0.571429,"avgChangeRate":0.064498},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.013887}],"exchange":"SEHK","name":"药明生物","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}